Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

August 01, 2020; Volume 98,Issue 2

Minireview

  • Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions
    You have access
    Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions
    Lloyd D. Fricker, Elyssa B. Margolis, Ivone Gomes and Lakshmi A. Devi
    Molecular Pharmacology August 2020, 98 (2) 96-108; DOI: https://doi.org/10.1124/mol.120.119388

Articles

  • Open Access
    Kinetic Analysis of the Early Signaling Steps of the Human Chemokine Receptor CXCR4
    Cristina Perpiñá-Viciano, Ali Işbilir, Aurélien Zarca, Birgit Caspar, Laura E. Kilpatrick, Stephen J. Hill, Martine J. Smit, Martin J. Lohse and Carsten Hoffmann
    Molecular Pharmacology August 2020, 98 (2) 72-87; DOI: https://doi.org/10.1124/mol.119.118448
  • You have access
    Modulation of Human Arylamine N-Acetyltransferase 1 Activity by Lysine Acetylation: Role of p300/CREB-Binding Protein and Sirtuins 1 and 2
    Neville J. Butcher, Rachel Burow and Rodney F. Minchin
    Molecular Pharmacology August 2020, 98 (2) 88-95; DOI: https://doi.org/10.1124/mol.119.119008
  • You have access
    Characterization of Meta-Iodobenzylguanidine (mIBG) Transport by Polyspecific Organic Cation Transporters: Implication for mIBG Therapy
    Antonio J. López Quiñones, David J. Wagner and Joanne Wang
    Molecular Pharmacology August 2020, 98 (2) 109-119; DOI: https://doi.org/10.1124/mol.120.119495
  • MicroRNA hsa-miR-1301-3p Regulates Human <em>ADH6</em>, <em>ALDH5A1</em> and <em>ALDH8A1</em> in the Ethanol-Acetaldehyde-Acetate Metabolic Pathway
    You have access
    MicroRNA hsa-miR-1301-3p Regulates Human ADH6, ALDH5A1 and ALDH8A1 in the Ethanol-Acetaldehyde-Acetate Metabolic Pathway
    Xubing Wang, Yanjie Zhao, Jiao Luo, Lin Xu, Xinmei Li, Yuan Jin, Chuanhai Li, Meiyao Feng, Ying Wang, Jing Chen, Yufei Hou, Qianwen Zhao, Jinquan Zhao, Baitang Ning, Yuxin Zheng and Dianke Yu
    Molecular Pharmacology August 2020, 98 (2) 120-129; DOI: https://doi.org/10.1124/mol.120.119693
  • You have access
    Novel c-Myc–Targeting Compound N, N-Bis (5-Ethyl-2-Hydroxybenzyl) Methylamine for Mediated c-Myc Ubiquitin-Proteasomal Degradation in Lung Cancer Cells
    Nicharat Sriratanasak, Korrakod Petsri, Apirat Laobuthee, Worawat Wattanathana, Chanida Vinayanuwattikun, Sudjit Luanpitpong and Pithi Chanvorachote
    Molecular Pharmacology August 2020, 98 (2) 130-142; DOI: https://doi.org/10.1124/mol.120.119719
  • You have access
    The Phosphodiesterase Inhibitor IBMX Blocks the Potassium Channel THIK-1 from the Extracellular Side
    Xinle Zou, Linus J. Conrad, Kristin Koschinsky, Günter Schlichthörl, Regina Preisig-Müller, Eugen Netz, Jens Krüger, Jürgen Daut and Vijay Renigunta
    Molecular Pharmacology August 2020, 98 (2) 143-155; DOI: https://doi.org/10.1124/molpharm.120.000011
  • You have access
    Structural Refinement of the Tubulin Ligand (+)-Discodermolide to Attenuate Chemotherapy-Mediated Senescence
    Boying Guo, Alicia Rodriguez-Gabin, Andrea E. Prota, Tobias Mühlethaler, Nan Zhang, Kenny Ye, Michel O. Steinmetz, Susan Band Horwitz, Amos B. Smith and Hayley M. McDaid
    Molecular Pharmacology August 2020, 98 (2) 156-167; DOI: https://doi.org/10.1124/mol.119.117457
  • You have access
    A Methyl Scan of the Pyrrolidinium Ring of Nicotine Reveals Significant Differences in Its Interactions with α7 and α4β2 Nicotinic Acetylcholine Receptors
    Hong Xing, Kristin W. Andrud, Ferenc Soti, Anne Rouchaud, Stephan C. Jahn, Ziang Lu, Yeh-Hyon Cho, Sophia Habibi, Patrick Corsino, Svetoslav Slavov, James R. Rocca, Jon M. Lindstrom, Ron J. Lukas and William R. Kem
    Molecular Pharmacology August 2020, 98 (2) 168-180; DOI: https://doi.org/10.1124/mol.119.118786

Errata

  • You have access
    Correction to “MicroRNA hsa-miR-1301-3p Regulates Human ADH6, ALDH5A1 and ALDH8A1 in the Ethanol-Acetaldehyde-Acetate Metabolic Pathway”
    Molecular Pharmacology August 2020, 98 (2) 181; DOI: https://doi.org/10.1124/molpharm.120.000109
  • You have access
    Correction to “CXL146, a Novel 4H-Chromene Derivative, Targets GRP78 to Selectively Eliminate Multidrug-Resistant Cancer Cells”
    Molecular Pharmacology August 2020, 98 (2) 182; DOI: https://doi.org/10.1124/molpharm.119.000110
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 98 (2)
Molecular Pharmacology
Vol. 98, Issue 2
1 Aug 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireview
  • Articles
  • Errata
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics